Public awareness of risk factors and screening for colorectal cancer in Europe

被引:92
作者
Keighley, MRB [1 ]
O'Morain, C
Giacosa, A
Ashorn, M
Burroughs, A
Crespi, M
Delvaux, M
Faivre, J
Hagenmuller, F
Lamy, V
Manger, F
Mills, HT
Neumann, C
Nowak, A
Pehrsson, A
Smits, S
Spencer, K
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Surg, Birmingham B15 2TH, W Midlands, England
[2] Tallaght Hosp, Dublin, Ireland
[3] Natl Inst Canc Res, Genoa, Italy
[4] Univ Tampere, FIN-33101 Tampere, Finland
[5] Royal Free Hosp, London NW3 2QG, England
[6] Natl Canc Inst Regina Elena, Rome, Italy
[7] CHU Rangueil, F-31054 Toulouse, France
[8] INSERM, EPI 0106, Registre Bourguignon Tumeurs Digest, Dijon, France
[9] Allgemeines Krankenhaus Altona, Hamburg, Germany
[10] L Warynski Silesian Med Acad, Katowice, Poland
[11] Univ Rotterdam Hosp, Rotterdam, Netherlands
[12] OLYMPUS Europa, Hamburg, Germany
关键词
colorectal cancer; public awareness; screening;
D O I
10.1097/01.cej.0000136575.01493.9b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is the commonest site for malignancy in Europe. The Commissioner for Health wishes to promote screening for colorectal, breast and cervical cancer in Europe. The aim of this study was to assess public knowledge of CRC in Europe and likely take up of free screening. To this end 20 710 members of the public from 21 European countries were interviewed by means of a regular survey amongst consumers (Omnibus survey) using 13 stem questions. Forty-eight per cent thought the population were at equal risk of CRC, only 57% were aware of age and 54% of family history as risk factors. Although 70% were aware of dietary factors, only 30% knew that lack of exercise might be a risk factor. Only 51% had knowledge of CIRC screening but 75% were 'very, or 'quite interested, in taking up faecal occult blood (FOB) screening if offered free. Barriers to screening were lack of awareness of risk (31 W, youth (22%) and an un-anaesthetic test (19%). There was a big cultural difference in willingness of the public to discuss bowel symptoms: there was a major barrier in Finland (91%), Britain (84%), Luxembourg (82%), Poland (81%) and Portugal (80%); less of a barrier in Spain (49%), Italy (44%) and Iceland (39%). In conclusion, the challenge of achieving high compliance for CRC screening must be a major objective amongst EU member states and non-aligned countries of Europe in the next decade, because it is known that the non-compliant group are those at greatest risk of death from CRC. This study has shown that awareness of CRC is low in Europe and that an educational programme will be essential to achieve high compliance for CRC screening as a means of reducing deaths from bowel cancer. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 16 条
[1]  
ALEXANDER F, 2003, UK COLORECTAL CANC S
[2]   Implementing screening for colorectal cancer - Issues remain about how to investigate those who screen positive [J].
Atkin, W .
BRITISH MEDICAL JOURNAL, 1999, 319 (7219) :1212-1213
[3]   RISK PERCEPTIONS AND PARTICIPATION IN COLORECTAL-CANCER SCREENING [J].
BLALOCK, SJ ;
DEVELLIS, BM ;
AFIFI, RA ;
SANDLER, RS .
HEALTH PSYCHOLOGY, 1990, 9 (06) :792-806
[4]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[5]   A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds [J].
Jorgensen, OD ;
Kronborg, O ;
Fenger, C .
GUT, 2002, 50 (01) :29-32
[6]  
KRONBORG O, 2004, IN PRESS SCAND J GAS
[7]   The colorectal adenoma-carcinoma sequence [J].
Leslie, A ;
Carey, FA ;
Pratt, NR ;
Steele, RJC .
BRITISH JOURNAL OF SURGERY, 2002, 89 (07) :845-860
[8]   Use of colonoscopy to screen asymptomatic adults for colorectal cancer [J].
Lieberman, DA ;
Weiss, DG ;
Bond, JH ;
Ahnen, DJ ;
Garewal, H ;
Chejfec, G ;
Harford, WV ;
Provenzale, D ;
Sontag, S ;
Schnell, T ;
Campbell, DR ;
Durbin, TE ;
Nelson, DB ;
Ewing, SL ;
Triadafilopoulos, G ;
Ramirez, FC ;
Lee, JG ;
Collins, JF ;
Fennerty, B ;
Johnston, TK ;
Corless, CT ;
McQuaid, KR ;
Sampliner, RE ;
Morales, TG ;
Fass, R ;
Smith, R ;
Maheshwari, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (03) :162-168
[9]   Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial [J].
Lund, JN ;
Scholefield, JH ;
Grainge, MJ ;
Smith, SJ ;
Mangham, C ;
Armitage, NC ;
Robinson, MH ;
Logan, RFA .
GUT, 2001, 49 (01) :91-96
[10]  
MAYBERRY JF, 2002, LANCET, V359, P1291